Performance characteristics of a microfluidic Lab-on-Chip electrophoresis system for high-density lipoprotein (HDL) subfraction separation and measurement

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 6, 2010, Pages 883-889

  Yang, Dan Hui D ^a   Konigshofer, Yves ^a   Dike, Jude ^a   Chang, Elaine ^b   Mueller, Odilo ^a  

^a AGILENT TECHNOLOGIES   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

Electrophoresis; HDL subfractions; High density lipoprotein(HDL) 2b; Lab on Chip

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; POLYMER;

ACCURACY; ARTICLE; ELECTROPHORESIS; LAB ON A CHIP; MICROFLUIDIC ANALYSIS; PARTICLE SIZE; PRIORITY JOURNAL; REPRODUCIBILITY;

CHOLESTEROL, HDL; CORONARY DISEASE; ELECTROPHORESIS; HUMANS; LIPOPROTEINS, HDL; MICROFLUIDIC ANALYTICAL TECHNIQUES;

EID: 77953208900     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.133     Document Type: Article

References (21)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001;285: 2486-2497
2. Buring JE, O'Connor GT, Goldhaber SZ. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation 1992;85:22-29
3. Superko HR, King S III. Lipid management to reduce cardiovascular risk: a new strategy is required. Circulation 2008;117: 560-568
4. Lindgren FT, Elliott HA, Gofman JW. The ultracentrifugal characterization and isolation of human blood lipids and lipoproteins, with applications to the study of atherosclerosis. J Phys Colloid Chem 1951;55:80-93.
5. Johansson J, Nilsson-Ehle P, Carlson LA, Hamsten A. The association of lipoprotein and hepatic lipase activities with high density lipoprotein subclass levels in men with myocardial infarction at a young age. Atherosclerosis 1991;86:111-122
6. Superko HR. Advanced lipoprotein testing and subfractionation are clinically useful. Circulation 2009;119:2383-2395
7. Calabresi L, Franceschini G, Sirtori M, Gianfranceschi G, Werba P, Sirtori CR. Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease. Atherosclerosis 1990;84:41-48
8. Mueller O, Chang E, Deng D, Franz T, Jing D, Kincaid R, et al. PROCAM study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfraction is independent of HDL cholesterol. Clin Chem Lab Med 2008; 46:490-498
9. Laakso M, Lehto S, PenttiläI, PyöräläK. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993;88:1421-1430
10. DeLalla OF, Gofman JW. Ultracentrifugal analysis of serum lipoproteins. Methods Biochem Anal 1954;1:459-478
11. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantification of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206-1223
12. Blanche PJ, Gong EL, Forte TM, Nichols AV. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 1981;665:408-419
13. Nichols AV, Blanche PJ, Shore VG, Gong EL. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma. Biochim Biophys Acta 1989;1001:325-337
14. Otvos JD, Jeyarajah EJ, Bennett DW. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 1991;37:377-386
15. Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006;26:847-870
16. Caulfield MP, Li S, Lee G, Blanche PJ, Salameh WA, Benner WH, et al. Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin Chem 2008;54: 1307-1316
17. Okazaki M, Usui S, Fukui A, Kubota I, Tomoike H. Component analysis of HPLC profile of unique lipoprotein subclass cholesterols for detection of coronary artery disease. Clin Chem 2006;52:2049-2053
18. Clinical and Laboratory Standards Institute (CLSI). Interference testing in clinical chemistry; approved guideline - 2nd ed. ISBN 1-56238-584-4, 2005.
19. Clinical and Laboratory Standard Institute (CLSI). Evaluation of precision performance of quantitative measurement methods; approved guideline - 2nd ed. ISBN 1-56238-542-9, 2004.
20. Demacker PN, van Sommeren-Zondag DF, Stalenhoef AF, Stuyt PM, van't Laar A. Ultracentrifugation in swing bucket and fixed angle rotors evaluated for isolation and determination of high density lipoprotein subfractions HDL 2 and HDL 3. Clin Chem 1983;29:656-663
21. Demacker PN, Hak-Lemmers HL, Hijmans AG, Baadenhuysen H. Evaluation of the dual-precipitation method for determination of cholesterol in high-density lipoprotein subfractions HDL 2 and HDL 3 in serum. Clin Chem 1986;32:819-825